147 related articles for article (PubMed ID: 38707658)
1. Paraneoplastic Vitiligo Associated With Adrenocortical Carcinoma.
Goodkin DA; Failor RA; Habra MA
JCEM Case Rep; 2024 May; 2(5):luae070. PubMed ID: 38707658
[TBL] [Abstract][Full Text] [Related]
2. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma.
Navarro-Fernandez I; Gonzalez-Vela C; Gomez-Fernandez C; Duran-Vian C; Reguero L; Gonzalez-Lopez M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):54-55. PubMed ID: 34477066
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo as a paraneoplastic syndrome preceding pituitary adenoma and subsequent acute lymphoblastic leukemia.
Au WY; Hon C; Chan AC; Sano T; Chan HH
Leuk Lymphoma; 2004 Aug; 45(8):1683-5. PubMed ID: 15370225
[TBL] [Abstract][Full Text] [Related]
4. Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical Carcinoma.
Murvelashvili N; Polanco PM; Khorsand SM; Marrero JA; Jia L; Mirfakhraee S; Else T; Habra MA; Cole S; Hamidi O
J Endocr Soc; 2022 Aug; 6(8):bvac101. PubMed ID: 35811575
[TBL] [Abstract][Full Text] [Related]
5. Multiple paraneoplastic syndromes: myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma.
Qiao J; Zhou G; Ding Y; Zhu D; Fang H
J Neurol Sci; 2011 Sep; 308(1-2):177-9. PubMed ID: 21689830
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data.
Rao H; Guo Z; Wen X; Zeng X; Wu L; Huang L
Front Oncol; 2022; 12():1099108. PubMed ID: 36713515
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report.
Yun SJ; Oh IJ; Park CK; Kim YC; Kim HB; Kim HK; Hong AR; Kim IY; Ahn SJ; Na KJ; Choi YD
Transl Lung Cancer Res; 2020 Aug; 9(4):1585-1590. PubMed ID: 32953529
[TBL] [Abstract][Full Text] [Related]
8. Generalized Vitiligo Following Radiation Therapy for a B2 Thymoma: A Case Report.
Sirody J; Orlinsky D; Simmons-O'Brien E
Cureus; 2023 Apr; 15(4):e37538. PubMed ID: 37193461
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
Grau C; Silverberg NB
Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
[TBL] [Abstract][Full Text] [Related]
10. Beyond skin white spots: Vitiligo and associated comorbidities.
Hu Z; Wang T
Front Med (Lausanne); 2023; 10():1072837. PubMed ID: 36910477
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo-Thyroid Disease Association: When, in Whom, and Why Should It Be Suspected? A Systematic Review.
Chivu AM; Bălășescu E; Pandia LD; Nedelcu RI; Brînzea A; Turcu G; Antohe M; Ion DA
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556267
[TBL] [Abstract][Full Text] [Related]
12. Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases.
Wong CL; Fok CK; Chan YK; Tam VH; Fung LM
Case Rep Endocrinol; 2022; 2022():7395050. PubMed ID: 36160179
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma.
Shetty I; Fuller S; Raygada M; Merino MJ; Thomas BJ; Widemann BC; Reilly KM; Pacak K; Del Rivero J
Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31917677
[TBL] [Abstract][Full Text] [Related]
14. Thymic Carcinoma With Multiple Paraneoplastic Disorders.
Alexakou Z; Liatsos G; Vasileiou N; Vamvakaris I; Mani I; Alexopoulou A
Am J Med Sci; 2021 Sep; 362(3):324-330. PubMed ID: 33961845
[TBL] [Abstract][Full Text] [Related]
15. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study.
van Geel N; Depaepe L; Speeckaert R
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1121-7. PubMed ID: 25286980
[TBL] [Abstract][Full Text] [Related]
16. Equine vitiligo-like depigmentation in grey horses is related to genes involved in immune response and tumor metastasis.
Druml T; Brem G; Velie B; Lindgren G; Horna M; Ricard A; Grilz-Seger G
BMC Vet Res; 2021 Oct; 17(1):336. PubMed ID: 34696794
[TBL] [Abstract][Full Text] [Related]
17. Vitiligo.
Kenney JA
Dermatol Clin; 1988 Jul; 6(3):425-34. PubMed ID: 3168334
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic Scleroderma: Are There Any Clues?
Jedlickova H; Durčanská V; Vašků V
Acta Dermatovenerol Croat; 2016 Apr; 24(1):78-80. PubMed ID: 27149136
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune Encephalitis as a Rare Paraneoplastic Syndrome in Adrenocortical Carcinoma.
Mohapatra D; Tripathi M; Ojha S; Meena JP; Chakrabarty B
Indian J Nucl Med; 2023; 38(4):376-378. PubMed ID: 38390536
[TBL] [Abstract][Full Text] [Related]
20. Immunological basis of melanoma-associated vitiligo-like depigmentation.
González R; Torres-López E
Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
